Oligonucleotide Therapeutics and Delivery Conference 2021
Evvnt Promotion / evvnt
22.09.2021 - 23.09.2021 Holiday Inn London - Kensington Forum, 97 Cromwell Road, SW7 4DN London, Großbritannien
Time: 09:00 - 17:30
Kongressthemen
Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. Their market growth: CAGR of 13.7% projected to reach USD 8.2 billion by 2024 is driven by their potential to provide more efficacious and less toxic alternatives to small molecules. They bring about the ability to affect targets that have been considered "non-draggable".
Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. Their market growth: CAGR of 13.7% projected to reach USD 8.2 billion by 2024 is driven by their potential to provide more efficacious and less toxic alternatives to small molecules. They bring about the ability to affect targets that have been considered "non-draggable".
Kongressorganizer (PCO)
SMI Group Limited
SMI Group Limited
Anfragen und Anmeldung:
https://go.evvnt.com/774501-0?pid=4832
Frau Jinna Sidhu
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
General Admission: GBP 1499.0, Early bird - Book by 28 May 2021: GBP 1299.0, Early bird - Book by 30 June 2021: GBP 1399.0
General Admission: GBP 1499.0, Early bird - Book by 28 May 2021: GBP 1299.0, Early bird - Book by 30 June 2021: GBP 1399.0
Teilnehmer erwartet
150
150
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
